| 高卫华 蔡琴 牟建军 赵黎 张卫卫.瑞舒伐他汀对冠心病患者血脂水平及颈动脉粥样硬化斑块硬化程度的影响[J].,2015,15(32):6283-6285 |
| 瑞舒伐他汀对冠心病患者血脂水平及颈动脉粥样硬化斑块硬化程度的影响 |
| Effect of Rosuvastatin on the Plasma Lipids Levels and the Degree of CarotidAtherosclerotic Plaques of Patients with Coronary Heart Disease |
| |
| DOI： |
| 中文关键词: 瑞舒伐他汀 冠心病 血脂 颈动脉粥样硬化 |
| 英文关键词: Rosuvastatin Coronary heart disease (CHD) Plasma lipid Carotid atherosclerosis |
| 基金项目:陕西省自然科学基金项目(2003C225) |
|
| 摘要点击次数: 833 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：探讨瑞舒伐他汀对冠心病患者血脂水平以及颈动脉粥样硬化斑块硬化程度的影响。方法：选择2013 年2 月至2014年
12 月我院收治的132 例冠心病患者作为研究对象，将其随机分为研究组(66 例)和对照组(66 例)，研究组应用瑞舒伐他汀(rosuvastatin
calcium, RC)治疗，对照组采用常规药物治疗，观察和比较两组患者的血脂水平变化情况及颈动脉粥样硬化斑块硬化(IMT)程
度的改善情况。结果：两组的总胆固醇(total c holesterol, T C)、低密度脂蛋白胆固醇(Low density lipoprotein cholesterol, LDL-C)、甘
油三酯(triglyceride, T G)水平较治疗前均有降低，高密度脂蛋白胆固醇(High density lipoprotein cholesterol, HDL-C)水平较治疗前
有升高，研究组变化更显著，组间差异有统计学意义(P<0.05)。两组颈动脉粥样硬化斑块硬化程度较治疗前有改善，研究组优于对
照组，差异有统计学意义(P<0.05)。研究组与对照组治疗总有效率分别为98.5%、71.2%，差异有统计学意义(P<0.05)。结论：瑞舒伐
他汀能够有效降低冠心病患者的血脂水平，并能改善其颈动脉粥样硬化的程度。 |
| 英文摘要: |
| Objective:To study the effect of rosuvastatin on the plasma lipids levels and the degree of carotid atherosclerotic
plaques of patients with coronary heart disease.Methods:From February 2013 to December 2014, 132 cases of patients with coronary
heart disease treated in our hospital were selected as the research object and randomly divided into the research group and the control
group, 66 cases in each group, the research group was treated by rosuvastatin calcium (RC), while the control group was treated by
conventional drug, the plasma lipids level and the changes of carotid atherosclerotic plaques sclerosis (IMT) degree were observed and
compared between two groups.Results:The total cholesterol(TC), low density lipoprotein cholesterol(LDL-C)), triglycerides(TG) levels
of both groups were significantly lower than those before treatment, while the high density lipoprotein cholesterol (HDL-C) level were
significantly higher than those before treatment, the research group changed more significantly, (P<0.05). The carotid atherosclerotic
plaques hardening degree were improved, the research group was better than that of control group (P<0.05). The total effective rates of
research group and control group were 98.5% and 71.2%, respectively, which was significantly higher in the research group(P<0.05).Conclusion:Rosuvastatin could effectively reduce the plasma lipid levels in patients with coronary heart disease, and improve the degree
of carotid atherosclerosis. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
